iBio (IBIO) Shares Outstanding (2010 - 2026)
iBio's Shares Outstanding came in at 104.06 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 891.1% from 10.5 million a year earlier but down 13.0% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Shares Outstanding (2010 - 2026) Analysis & Trends
Going back to fiscal Q1 2011, iBio's Shares Outstanding data covers 64 quarters.
- Shares Outstanding has increased in each of the last four fiscal years, with a five-year compound annual growth rate of 60.5% (FY2021 to FY2026).
- Going back by fiscal year, Shares Outstanding was 10.5 million in FY2025 (+174.1%), 3.83 million in FY2024 (+525.7%), 612,250 in FY2023 (+40.4%) and 436,050 in FY2022 (-95.5%).
- The five-year range for quarterly Shares Outstanding is 436,050 (fiscal Q4 2022) to 119.6 million (fiscal Q3 2026).
- The fastest year-over-year change in Shares Outstanding over five years came in fiscal Q2 2026 (growth of 985.6%), and the weakest in fiscal Q1 2023 (a decline of 95.9%).
- Business Quant data shows IBIO's Shares Outstanding at 119.6 million (Q3 2026), 99.13 million (Q2 2026) and 52.98 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.70 Mn |
| 10 | iBio | 122.79 Mn | 122.79 Mn | - | 104.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 104.06 Mn |
| Mar 31, 2026 | 119.60 Mn |
| Dec 31, 2025 | 99.13 Mn |
| Sep 30, 2025 | 52.98 Mn |
| Jun 30, 2025 | 10.50 Mn |
| Mar 31, 2025 | 9.86 Mn |
| Dec 31, 2024 | 9.13 Mn |
| Sep 30, 2024 | 8.63 Mn |
| Jun 30, 2024 | 3.83 Mn |
| Mar 31, 2024 | 3.71 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 612,250.00 |
| Mar 31, 2023 | 659,200.00 |
| Dec 31, 2022 | 490,350.00 |
| Sep 30, 2022 | 442,100.00 |
| Jun 30, 2022 | 436,050.00 |
| Mar 31, 2022 | 10.90 Mn |
| Dec 31, 2021 | 10.90 Mn |
| Sep 30, 2021 | 10.89 Mn |
API Access
iBio Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();